{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:30:11Z","timestamp":1795044611185,"version":"4.10.2"},"reference-count":22,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Number of reflux episodes, an adjunctive metric on pH-impedance monitoring, is\n              incompletely studied. We aimed to determine if number of reflux episodes associates\n              with therapeutic outcome in regurgitation predominant gastro-oesophageal reflux\n              disease (GERD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We performed post hoc analysis of postintervention pH-impedance data from adult\n              patients with moderate\/severe regurgitation despite QD proton pump inhibitor (PPI),\n              randomised to either two times a day PPI or magnetic sphincter augmentation (MSA) in\n              2:1 allocation. After 6 and 12 months, symptom response was defined by improvement in\n              Foregut Symptom Questionnaire (FSQ) regurgitation score to none or minimal, \u226550%\n              reduction in GERD health-related quality of life (HRQL) score and satisfaction with\n              therapy. Univariate and multivariate analyses were performed to determine predictors\n              of symptom improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 152 randomised patients, 123 (age 46.9\u00b11.2\u2009year, 43% female) had complete\n              data. Symptom and satisfaction scores significantly improved after MSA compared with\n              two times a day PPI. Both acid exposure time (13.4%\u00b10.7%\u2009to 1.3\u00b10.2%, p&lt;0.001) and\n              reflux episodes (86\u00b14\u2009to 48\u00b14, p&lt;0.001) declined with therapy. Reduction to &lt;40\n              reflux episodes was significantly more frequent in those with symptom response by FSQ\n              regurgitation score, GERD HRQL score and satisfaction with therapy (p\u22640.03 for each);\n              &lt;35 episodes performed better on receiver operating characteristic analysis. On\n              multivariate analysis, improvement in regurgitation score remained independently\n              predictive of satisfaction with therapy (p&lt;0.001 for each). In patients crossing\n              over to MSA, &gt;80 episodes pretreatment predicted improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Reduction of reflux episodes on pH-impedance to physiological levels associates\n              with improved outcomes, while pathological levels predict improvement with MSA in\n              regurgitation predominant GERD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trail registration number<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT02505945\">NCT02505945<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2020-321395","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T17:15:38Z","timestamp":1590686138000},"page":"450-455","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":47,"title":["Number of reflux episodes on pH-impedance monitoring associates with improved\n            symptom outcome and treatment satisfaction in gastro-oesophageal reflux disease (GERD)\n            patients with regurgitation"],"prefix":"10.1136","volume":"70","clinical-trial-number":[{"clinical-trial-number":"nct02505945","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02505945","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Benjamin D","family":"Rogers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis R","family":"Valdovinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Crowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7912-4000","authenticated-orcid":false,"given":"Reginald","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo F","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3388-0660","authenticated-orcid":false,"given":"C Prakash","family":"Gyawali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"2021052500250866000_70.3.450.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00630.x"},{"key":"2021052500250866000_70.3.450.2","doi-asserted-by":"publisher","DOI":"10.1111\/dote.12495"},{"key":"2021052500250866000_70.3.450.3","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.146"},{"key":"2021052500250866000_70.3.450.4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/j.gastro.2017.07.049","article-title":"Management of gastroesophageal reflux disease","volume":"154","author":"Gyawali","year":"2018","journal-title":"Gastroenterology"},{"key":"2021052500250866000_70.3.450.5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.gastro.2014.10.009","article-title":"Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial","volume":"148","author":"Hunter","year":"2015","journal-title":"Gastroenterology"},{"key":"2021052500250866000_70.3.450.6","article-title":"Magnetic sphincter augmentation superior to proton pump inhibitors for regurgitation in a 1-year randomized trial","author":"Bell","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2021052500250866000_70.3.450.7","doi-asserted-by":"crossref","first-page":"e13067","DOI":"10.1111\/nmo.13067","article-title":"Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group","volume":"29","author":"Roman","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"2021052500250866000_70.3.450.8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314722"},{"key":"2021052500250866000_70.3.450.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.08.029"},{"key":"2021052500250866000_70.3.450.10","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.224824"},{"key":"2021052500250866000_70.3.450.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2018.07.007"},{"key":"2021052500250866000_70.3.450.12","first-page":"780","article-title":"Value of physiologic assessment of foregut symptoms in a surgical practice","volume":"114","author":"Costantini","year":"1993","journal-title":"Surgery"},{"key":"2021052500250866000_70.3.450.13","first-page":"217","article-title":"Quality of life scale for gastroesophageal reflux disease","volume":"183","author":"Velanovich","year":"1996","journal-title":"J Am Coll Surg"},{"key":"2021052500250866000_70.3.450.14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300798"},{"key":"2021052500250866000_70.3.450.15","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/nmo.12666","article-title":"Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux","volume":"27","author":"Roman","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"2021052500250866000_70.3.450.16","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.033290"},{"key":"2021052500250866000_70.3.450.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.10.041"},{"key":"2021052500250866000_70.3.450.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2006.00825.x"},{"key":"2021052500250866000_70.3.450.19","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.646"},{"key":"2021052500250866000_70.3.450.20","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.054981"},{"key":"2021052500250866000_70.3.450.21","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.24840"},{"key":"2021052500250866000_70.3.450.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811424"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2020-321395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T13:53:21Z","timestamp":1621950801000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2020-321395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,2,5]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1136\/gutjnl-2020-321395"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2020-321395","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738043874.793585255","asserted-by":"object"}]},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]}}}